1. Canadian findings on AstraZeneca COVID-19 Vaccine and COVISHIELD

   News item 01 May 2021 Pages: 1 - 1

2. PRAC: blood clots with Janssen's COVID-19 vaccine

   News item 01 May 2021 Pages: 2 - 2

3. DAA treatment for hepatitis C: risk of serious pulmonary and cardiac AEs

   Clinical study 01 May 2021 Pages: 3 - 3

4. Drug-induced anaphylaxis: most frequently caused by NSAIDs

   Clinical study 01 May 2021 Pages: 4 - 4

5. Hormonal replacement therapy may reduce risk of colorectal cancer

   Clinical study 01 May 2021 Pages: 5 - 5

6. Hyponatraemia and SSRIs: time-dependent association?

   Clinical study 01 May 2021 Pages: 6 - 6

7. Impact of risk evaluation and mitigation strategy (REMS) programs

   Clinical study 01 May 2021 Pages: 7 - 7

8. Ivermectin vs benzimidazoles in sub-Saharan Africa vs RoW

   Clinical study 01 May 2021 Pages: 8 - 8

9. Post-discharge anticoagulants in elderly: early vs late adverse events

   Clinical study 01 May 2021 Pages: 9 - 9

10. SGLT2 inhibitors increase risk of genital infections and ketoacidosis

    Clinical study 01 May 2021 Pages: 10 - 10

11. Other adverse reaction research

    News item 01 May 2021 Pages: 11 - 11

12. Abacavir/dolutegravir/lamivudine

    Case report 01 May 2021 Pages: 12 - 12

13. Acenocoumarol/cotrimoxazole/warfarin

    Case report 01 May 2021 Pages: 13 - 13

14. Aciclovir/elotuzumab/zoledronic-acid

    Case report 01 May 2021 Pages: 14 - 14

15. Adalimumab

    Case report 01 May 2021 Pages: 15 - 15

16. Adalimumab

    Case report 01 May 2021 Pages: 16 - 16

17. Adalimumab

    Case report 01 May 2021 Pages: 17 - 17

18. Adalimumab

    Case report 01 May 2021 Pages: 18 - 18

19. Adalimumab/etanercept/infliximab

    Case report 01 May 2021 Pages: 19 - 19

20. Adalimumab/infliximab/methotrexate

    Case report 01 May 2021 Pages: 20 - 20

21. Adefovir

    Case report 01 May 2021 Pages: 21 - 21

22. Adefovir/lamivudine

    Case report 01 May 2021 Pages: 22 - 22

23. Adenosine

    Case report 01 May 2021 Pages: 23 - 23

24. Alendronic-acid

    Case report 01 May 2021 Pages: 24 - 24

25. Allopurinol

    Case report 01 May 2021 Pages: 25 - 25

26. Alteplase

    Case report 01 May 2021 Pages: 26 - 26

27. Alteplase

    Case report 01 May 2021 Pages: 27 - 27

28. Amikacin

    Case report 01 May 2021 Pages: 28 - 28

29. Amiodarone

    Case report 01 May 2021 Pages: 29 - 29

30. Amiodarone

    Case report 01 May 2021 Pages: 30 - 30

31. Amiodarone misuse

    Case report 01 May 2021 Pages: 31 - 31

32. Amiodarone/bisoprolol

    Case report 01 May 2021 Pages: 32 - 32

33. Amlodipine/benazepril

    Case report 01 May 2021 Pages: 33 - 33

34. Amlodipine/calcium/soya-oil-emulsion

    Case report 01 May 2021 Pages: 34 - 34

35. Amlodipine/carvedilol

    Case report 01 May 2021 Pages: 35 - 35

36. Amoxicillin/clavulanic-acid

    Case report 01 May 2021 Pages: 36 - 36

37. Amphotericin-B-liposomal

    Case report 01 May 2021 Pages: 37 - 37

38. Amphotericin-B/fluconazole

    Case report 01 May 2021 Pages: 38 - 38

39. Anti-CD19-CAR-transduced-T-cells/cyclophosphamide/fludarabine

    Case report 01 May 2021 Pages: 39 - 39

40. Antiarrhythmics

    Case report 01 May 2021 Pages: 40 - 40

41. Antibacterials

    Case report 01 May 2021 Pages: 41 - 41

42. Anticoagulants/antiplatelets

    Case report 01 May 2021 Pages: 42 - 42

43. Antiepileptic drugs/midazolam

    Case report 01 May 2021 Pages: 43 - 43

44. Antiepileptic-drugs

    Case report 01 May 2021 Pages: 44 - 44

45. Antiepileptic-drugs/hydrocortisone

    Case report 01 May 2021 Pages: 45 - 45

46. Antifungals

    Case report 01 May 2021 Pages: 46 - 46

47. Antineoplastics

    Case report 01 May 2021 Pages: 47 - 47

48. Antineoplastics

    Case report 01 May 2021 Pages: 48 - 48

49. Antineoplastics

    Case report 01 May 2021 Pages: 49 - 49

50. Antineoplastics

    Case report 01 May 2021 Pages: 50 - 50